Use of Chinese Medicine and Subsequent Surgery in Women with Uterine Fibroid: A Retrospective Cohort Study
Table 1
Comparison of socio-demographic factors and co-morbidities between Chinese medicine (CM) users and nonusers in patients with uterine fibroids.
CM Nonusers
CM Users
Total
valuea
%
%
%
Age, years
<0.0001
<20
18
0.40
110
0.90
128
0.77
20–29
268
6.02
1151
9.41
1419
8.50
30–39
1120
25.2
3603
29.4
4723
28.3
40–49
2394
53.8
5643
46.1
8037
48.2
≥50
652
14.7
1731
14.1
2383
14.3
Mean ± SD
42.9 ± 8.20
41.6 ± 8.84
41.9 ± 8.69
<0.0001
Income, US$ per month
0.86
<564.3
1178
26.5
3276
26.8
4454
26.7
564.3–656.5
868
19.5
2438
19.9
3306
19.8
656.6–779.6
1293
29.0
3514
28.7
4807
28.8
≥779.7
1113
25.0
3010
24.6
4123
24.7
Occupational status
0.009
White collar
2454
55.1
7015
57.3
9469
56.8
Blue collar
1500
33.7
4016
32.8
5516
33.1
Others
498
11.2
1202
9.83
1700
10.2
Area
<0.0001
Northern Taiwan
2288
51.4
5505
45.0
7793
46.7
Central Taiwan
604
13.6
2353
19.2
2957
17.7
Southern Taiwan
1364
30.6
3852
31.5
5216
31.3
Eastern Taiwan and offshore islands
196
4.40
523
4.28
719
4.31
Comorbidity
Excessive menstruation
782
17.6
2718
22.2
3500
21.0
<0.0001
Iron-deficiency anemia
473
10.6
1549
12.7
2022
12.1
0.0004
Dysmenorrhea
555
12.5
2571
21.0
3126
18.7
<0.0001
Infertility
9
0.20
94
0.77
103
0.62
<0.0001
aChi-square test and -test.
We are committed to sharing findings related to COVID-19 as quickly as possible. We will be providing unlimited waivers of publication charges for accepted research articles as well as case reports and case series related to COVID-19. Review articles are excluded from this waiver policy. Sign up here as a reviewer to help fast-track new submissions.